Literature DB >> 25879159

Is there association between TLR9 polymorphism and SLE susceptibility?

Qian Xi1, Yun Liao1, Yongkang Wu1, Lanlan Wang2.   

Abstract

After reading the article "Susceptibility to SLE in South Indian Tamils may be influenced by genetic selection pressure on TLR2 and TLR9 genes", we have some doubt. As the differences existed in genetic risk factors, SLE symptoms, and disease severity between the childhood-onset and adult-onset SLE patients, the association analyses in study population including both childhood-onset and adult-onset SLE patients might be inappropriate. Besides, in order to explore whether TLR9 (-1237C/T) polymorphism impact SLE occurrence, we reviewed current studies and conducted a meta-analysis. The results of meta-analysis showed no significant correlation between TLR9 (-1237C/T) and SLE susceptibility in total population (allele model OR=0.97, 95%CI (0.81-1.14)), or in Caucasians (allele model OR=1.05, 95%CI (0.72-1.39)) and in Asians (allele model OR=0.94, 95%CI (0.54-1.35)). Therefore, confirmative evidence reveals that TLR9 (-1237C/T) polymorphism does not correlate with SLE susceptibility.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genetic polymorphism; SNP; Systemic lupus erythematosus; Toll-like receptor 9

Mesh:

Substances:

Year:  2015        PMID: 25879159     DOI: 10.1016/j.molimm.2015.03.252

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

Review 1.  TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.

Authors:  Duan Wang; Chao Zhang; Zongke Zhou; Fuxing Pei
Journal:  Rheumatol Int       Date:  2015-12-07       Impact factor: 2.631

2.  Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis.

Authors:  N Elloumi; R Fakhfakh; O Abida; L Ayadi; S Marzouk; H Hachicha; M Fourati; Z Bahloul; M N Mhiri; K Kammoun; H Masmoudi
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.